Regular single-target siRNA synthesis
Cat.No: {{good_number}} Hot
Price:
Promotion price: USD${{favour_price == selected_record.event_price ? favour_price : selected_record.price}}
Unit:
  • {{item}}
Unit:
  • {{item}}
Please complete your information before placing an orderCertify

Product Details

In the field of gene function research and drug development, the primary advantage of siRNAs over small molecule inhibitors, chemotherapeutics or antibodies is their high specificity and high throughput screening. siRNAs can target different target genes by optimizing the location and modification of RNAi targeting sequences to achieve gene expression silencing and further rapid development of new drugs, and their screening and development timelines are usually better than those of chemotherapeutics and antibodies. The screening and development time is usually better than that of chemical drugs and antibody drugs.


siRNA   service

 Regular siRNA

Modified siRNA

UHP siRNA

Animal-grade in vivo-siRNA

Application

Suitable for preliminary screening of RNAi in various   cells

Increase siRNA stability and effectively inhibit   target gene expression

Ensure ultra-high performance of silencing   specificity, efficiency and stability of each siRNA sequence

Can be injected directly into the animal for systemic   or partial drug delivery


Advantages

1. Professional technical design, special optimized sequences and modifications to ensure that siRNA can achieve more than 70% silencing effect;

2. Designing synthetic siRNAs for more regions of the same mRNA to improve the success rate of silencing target genes;

3. After-sales commitment: we promise that the experimental data you provide (transfection efficiency picture or positive control results [can be either, need to achieve 80% transfection efficiency or positive interference effect of 70%] with qPCR primers and the original results), through qPCR identification, the set of 3 pairs of siRNA to determine that no one in any one cell does not reach 70% of the silencing effect, commitment to redesign and free synthesis of another 3 pairs of siRNA for the target gene once and give the corresponding control.

Component

S/N

Services

Specification

PRsi001

siRNA regular single-target synthesis

2.5nmol
  5nmol
  10nmol
  100nmol
  Others

PRsiu002

UHP- siRNA chemical modified single-target synthesis

2.5nmol
  5nmol
  10nmol
  100nmol
  Others

PRsit003

siRNA   regular 1/3 package synthesis

5nmol*3

PRsit003

siRNA   regular 2/5 package synthesis

5nmol*5

PRsit004

siRNA   regular 1/3 ready-to-use package synthesis

5nmol*3

PRsit004

siRNA   regular 2/5 Ready-to-Use Package Synthesis

5nmol*5

Prsiut005

UHP-siRNA   chemical modified 1/3 package synthesis

5nmol*3

Prsiut005

UHP-siRNA   chemical modified 2/5 package synthesis

5nmol*5

Prsiut006

UHP-siRNA   chemical modified 1/3 ready-to-use package synthesis

5nmol*3

Prsiut006

UHP-siRNA   chemical modified 2/5 ready-to-use package synthesis

5nmol*5